Fortrea Holdings Inc stock is traded at $18.55, with a volume of 1,542,112. It is down -7.94% in the last 24 hours and down -18.57% over the past month. Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.
Previous Close:
$20.15
Open:
$19.89
24h Volume:
1,542,112
Relative Volume:
0.99
Market Cap:
$1.79B
Revenue:
$2.71B
Net Income/Loss:
-$446.90M
P/E Ratio:
-
EPS:
-$4.91
Net Cash Flow:
$190.40M
1W Performance:
-8.17%
1M Performance:
-18.57%
6M Performance:
+35.40%
1Y Performance:
+84.76%
1-Day Range:
$18.30$20.52
1-Week Range:
$18.30$21.23
52-Week Range:
$8.55$26.16
Fortrea Holdings Inc Stock (FTRE) Company Profile
Name
Fortrea Holdings IncSector
HealthcareIndustry
BiotechnologyPhone
877-495-0816Address
8 MOORE DRIVE, DURHAM, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS